MARC record from Internet Archive

LEADER: 02585cam a22003257a 4500
001 2007936362
003 DLC
005 20080722170705.0
008 070829s2008 nyua b 101 0 eng d
010 $a 2007936362
020 $a9780387738970
020 $a0387738975
035 $a(OCoLC)ocn172984359
040 $aBTCTA$cBTCTA$dBAKER$dYDXCP$dBGU$dCLU$dCOU$dDLC
042 $alccopycat
050 00 $aRC270.8$b.T34 2008
082 00 $a616.99/406$222
245 00 $aTargeted therapies in cancer :$bmyth or reality? /$cFrancesco Colotta, Alberto Mantovani, editors.
260 $aNew York :$bSpringer,$cc2008.
300 $aviii, 191 p. :$bill. ;$c25 cm.
440 0 $aAdvances in experimental medicine and biology, ;$vv. 610
500 $aCollection of contributions to a meeting held September 2005 in Milan.
504 $aIncludes bibliographical references and index.
505 0 $aCausality in medicine / Giulio Giorello -- The evolution of the biomedical paradigm in oncology : implications for cancer therapy / Gilberto Corbellini and Chiara Preti -- Anticancer drug discovery and development / Francesco Colotta -- Beyond VEGF : targeting tumor growth and angiogenesis via alternative mechanisms / James Christensen and Kenna Anderes -- Aurora kinases and their inhibitors : more than one target and one drug / Patrizia Carpinelli and Jürgen Moll -- Signalling pathways and adhesion molecules as targets for antiangiogenesis therapy in tumors / Gianfranco Bazzoni -- Developing T-cell therapies for cancer in an academic setting / Malcolm K. Brenner -- Anticancer cell therapy with TRAIL-armed CD34⁺ progenitor cells / Carmelo Carlo-Stella ... [et al.] -- Linking inflammation reactions to cancer : novel targets for therapeutic strategies / Alberto Mantovani ... [et al.] -- Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors : what lessons have we learned? / Manuel Hidalgo -- GIST as the model of paradigm shift towards targeted therapy of solid tumors : update and perspective on trial design / Jaap Verweij, Caroline Seynaeve, and Stefan Sleijfer -- Monoclonal antibodies in the treatment of malignant lymphomas / Bertrand Coiffier -- Molecular network analysis using reverse phase protein microarrays for patient tailored therapy / Runa Speer ... [et al.]
650 0 $aCancer$xTreatment.
650 12 $aNeoplasms$xdrug therapy$vCongresses.
650 12 $aNeoplasms$xphysiopathology$vCongresses.
650 22 $aAntineoplastic Agents$xtherapeutic use$vCongresses.
700 1 $aColotta, Francesco.
700 1 $aMantovani, Alberto.